Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 18, 2002. The report details a specific corporate action regarding the repurchase of ordinary shares authorized by shareholders at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 865,000 ordinary shares
- Purchase Price: 1,150.23p per share
- Transaction Date: December 18, 2002
- Use of Proceeds: Shares were purchased for cancellation
Material Changes
The filing reports a reduction in the company's outstanding share count due to the cancellation of 865,000 shares. No other material changes to operations, assets, or liabilities are disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a routine disclosure of a completed share buyback transaction.
Key Facts for Investor Verification
- Verify the total number of shares authorized for repurchase at the May 20, 2002 Annual General Meeting to determine remaining buyback capacity.
- Confirm the total cost of the repurchase (865,000 shares x 1,150.23p) against the company's cash position in the most recent full financial report.
- Check subsequent filings to see if further repurchases were made under the same authority.